BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 27112942)

  • 1. Health outcomes and economic consequences of using angiotensin-converting enzyme inhibitors in comparison with angiotensin receptor blockers in the treatment of arterial hypertension in the contemporary Polish setting.
    Wrona W; Budka K; Filipiak KJ; Niewada M; Wojtyniak B; Zdrojewski T
    Kardiol Pol; 2016; 74(9):1016-24. PubMed ID: 27112942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Updates on the treatment of essential hypertension: a summary of AHRQ's comparative effectiveness review of angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, and direct renin inhibitors.
    Powers B; Greene L; Balfe LM
    J Manag Care Pharm; 2011 Oct; 17(8 Suppl):S1-14. PubMed ID: 22088101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of drug price adjustments on utilization of and expenditures on angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in Taiwan.
    Huang SH; Hsu CN; Yu SH; Cham TM
    BMC Public Health; 2012 May; 12():288. PubMed ID: 22521158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A systematic review and meta-analysis of the use of renin-angiotensin system drugs and COVID-19 clinical outcomes: What is the evidence so far?
    Kurdi A; Abutheraa N; Akil L; Godman B
    Pharmacol Res Perspect; 2020 Dec; 8(6):e00666. PubMed ID: 33084232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a step-therapy program for angiotensin receptor blockers on antihypertensive medication utilization patterns and cost of drug therapy.
    Yokoyama K; Yang W; Preblick R; Frech-Tamas F
    J Manag Care Pharm; 2007 Apr; 13(3):235-44. PubMed ID: 17407390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible ways to enhance renin-angiotensin prescribing efficiency: Republic of Serbia as a case history?
    Kalaba M; Godman B; Vuksanović A; Bennie M; Malmström RE
    J Comp Eff Res; 2012 Nov; 1(6):539-49. PubMed ID: 24236473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Pivotal Role of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers in Hypertension Management and Cardiovascular and Renal Protection: A Critical Appraisal and Comparison of International Guidelines.
    Alcocer LA; Bryce A; De Padua Brasil D; Lara J; Cortes JM; Quesada D; Rodriguez P
    Am J Cardiovasc Drugs; 2023 Nov; 23(6):663-682. PubMed ID: 37668854
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiotensin-converting enzyme inhibitors (ACEIs), not angiotensin receptor blockers (ARBs), are preferred and effective mode of therapy in high cardiovascular risk patients.
    Vijan SG
    J Indian Med Assoc; 2009 Mar; 107(3):178-82. PubMed ID: 19810392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness Analyses of Antihypertensive Medicines: A Systematic Review.
    Park C; Wang G; Durthaler JM; Fang J
    Am J Prev Med; 2017 Dec; 53(6S2):S131-S142. PubMed ID: 29153114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Economic evaluations of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers in type 2 diabetic nephropathy: a systematic review.
    Huang Y; Zhou Q; Haaijer-Ruskamp FM; Postma MJ
    BMC Nephrol; 2014 Jan; 15():15. PubMed ID: 24428868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitors effect on endothelial dysfunction: a meta-analysis of randomised controlled trials.
    Shahin Y; Khan JA; Samuel N; Chetter I
    Atherosclerosis; 2011 May; 216(1):7-16. PubMed ID: 21411098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of hypertension and renin-angiotensin system inhibitors in aortic stenosis.
    Capoulade R; Clavel MA; Mathieu P; Côté N; Dumesnil JG; Arsenault M; Bédard E; Pibarot P
    Eur J Clin Invest; 2013 Dec; 43(12):1262-72. PubMed ID: 24117162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ACEIs for cardiovascular risk reduction--have we taken our eye off the ball?
    Sindone A; Erlich J; Perkovic V; Suranyi M; Newman H; Lee C; Barin E; Roger SD
    Aust Fam Physician; 2013 Sep; 42(9):634-8. PubMed ID: 24024224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative risk for angioedema associated with the use of drugs that target the renin-angiotensin-aldosterone system.
    Toh S; Reichman ME; Houstoun M; Ross Southworth M; Ding X; Hernandez AF; Levenson M; Li L; McCloskey C; Shoaibi A; Wu E; Zornberg G; Hennessy S
    Arch Intern Med; 2012 Nov; 172(20):1582-9. PubMed ID: 23147456
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heart failure patients receiving ACEIs/ARBs were less likely to be hospitalized or to use emergency care in the following year.
    Chen JY; Kang N; Juarez DT; Yermilov I; Braithwaite RS; Hodges KA; Legorreta A; Chung RS
    J Healthc Qual; 2011; 33(4):29-36. PubMed ID: 21733022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiotensin converting enzyme inhibitors and angiotensin receptor blockers in the treatment of hypertension: should they be used together?
    Verdecchia P; Angeli F; Mazzotta G; Ambrosio G; Reboldi G
    Curr Vasc Pharmacol; 2010 Nov; 8(6):742-6. PubMed ID: 20626343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiotensin converting enzyme inhibitors effect on arterial stiffness and wave reflections: a meta-analysis and meta-regression of randomised controlled trials.
    Shahin Y; Khan JA; Chetter I
    Atherosclerosis; 2012 Mar; 221(1):18-33. PubMed ID: 22209214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of delisting ARBs, apart from losartan, on ARB utilisation patterns in Denmark: implications for other countries.
    Hesse U; Godman B; Petzold M; Martin A; Malmström RE
    Appl Health Econ Health Policy; 2013 Dec; 11(6):677-85. PubMed ID: 24105097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescriptions for angiotensin-converting enzyme inhibitors/angiotensin receptor blockers and monitoring of serum creatinine and potassium in patients with chronic kidney disease.
    Wang PT; Huang YB; Lin MY; Chuang PF; Hwang SJ
    Kaohsiung J Med Sci; 2012 Sep; 28(9):477-83. PubMed ID: 22974666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.